Alfact Innovation presents phase II results for ALF-5755 in AIH/HBV-related liver disease Nov. 12, 2013
New fusion proteins to reactivate apoptosis in TRAIL/Apo-2L-resistant cancer cells described Nov. 11, 2013
CFI-400945 as a potent and selective first-in-class PLK-4 inhibitor for the treatment of cancer Nov. 8, 2013
RSS